These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 2108852

  • 1. Role of aspirin with thrombolytic therapy in acute myocardial infarction.
    Hennekens CH.
    Chest; 1990 Apr; 97(4 Suppl):151S-155S. PubMed ID: 2108852
    [Abstract] [Full Text] [Related]

  • 2. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    Lancet; 1990 Jul 14; 336(8707):65-71. PubMed ID: 1975321
    [Abstract] [Full Text] [Related]

  • 3. Thrombolytic therapy for myocardial infarction.
    Guerci AD.
    Md Med J; 1990 Apr 14; 39(4):377-81. PubMed ID: 2110282
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic and thrombolytic therapies for acute myocardial infarction.
    Godfried SL, Gaziano JM, Hennekens CH.
    J Cardiovasc Risk; 1996 Oct 14; 3(5):453-7. PubMed ID: 9048261
    [Abstract] [Full Text] [Related]

  • 5. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators.
    N Engl J Med; 1993 Sep 02; 329(10):673-82. PubMed ID: 8204123
    [Abstract] [Full Text] [Related]

  • 6. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
    Mahaffey KW, Granger CB, Collins R, O'Connor CM, Ohman EM, Bleich SD, Col JJ, Califf RM.
    Am J Cardiol; 1996 Mar 15; 77(8):551-6. PubMed ID: 8610601
    [Abstract] [Full Text] [Related]

  • 7. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM.
    JAMA; 1996 Mar 13; 275(10):777-82. PubMed ID: 8598594
    [Abstract] [Full Text] [Related]

  • 8. Current issues concerning thrombolytic therapy for acute myocardial infarction.
    Hennekens CH, O'Donnell CJ, Ridker PM, Marder VJ.
    J Am Coll Cardiol; 1995 Jun 13; 25(7 Suppl):18S-22S. PubMed ID: 7775709
    [Abstract] [Full Text] [Related]

  • 9. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.
    Jafri SM, Walters BL, Borzak S.
    J Intensive Care Med; 1995 Jun 13; 10(2):54-63. PubMed ID: 10172420
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic therapy for acute myocardial infarction.
    O'Donnell CJ, Ridker PM, Hebert PR, Hennekens CH.
    J Am Coll Cardiol; 1995 Jun 13; 25(7 Suppl):23S-29S. PubMed ID: 7775710
    [Abstract] [Full Text] [Related]

  • 11. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP.
    Eur Heart J; 1994 Jan 13; 15(1):2-4. PubMed ID: 8174579
    [No Abstract] [Full Text] [Related]

  • 12. Thrombolytic therapy: then and now.
    Cole PL.
    Heart Lung; 1991 Sep 13; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [Abstract] [Full Text] [Related]

  • 13. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M, Cohen-Solal A, Spriet A.
    Arch Mal Coeur Vaiss; 1989 Oct 13; 82 Spec No 3():27-33. PubMed ID: 2512885
    [Abstract] [Full Text] [Related]

  • 14. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul 14; 336(8707):71-5. PubMed ID: 1975322
    [Abstract] [Full Text] [Related]

  • 15. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W, Schmutzler H.
    Herz; 1994 Dec 14; 19(6):336-52. PubMed ID: 7843690
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E.
    G Ital Cardiol; 1998 Jan 14; 28(1):3-11. PubMed ID: 9493040
    [Abstract] [Full Text] [Related]

  • 17. [Coronary thrombolysis in patients with acute myocardial infarction].
    Kambara H, Fudo T, Ono S.
    Kokyu To Junkan; 1992 Jun 14; 40(6):537-47. PubMed ID: 1620990
    [No Abstract] [Full Text] [Related]

  • 18. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A, Jang IK, Fuster V.
    Coron Artery Dis; 1994 Apr 14; 5(4):297-305. PubMed ID: 8044341
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators.
    N Engl J Med; 1993 Nov 25; 329(22):1615-22. PubMed ID: 8232430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.